300284.SZ
苏交科
SZSE · M 科研服务 · CN
CNY 5.15
−0.96%Year over year
Reported trailing growth
- Revenue
- -9.0%
- EBITDA
- —
- EBIT
- -77.6%
- EPS
- -90.1%
- Free cash flow
- +240.7%
- Operating cash flow
- +175.8%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -7.3%
- EBITDA
- -37.1%
- EBIT
- -57.5%
- Net income
- -65.9%
- EPS
- -65.9%
- Free cash flow
- +28.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026